Conversion rate of tuberculosis screening tests among dermatology patients treated with tumor necrosis factor inhibitors

• Main Authors: Sarah F Alsukait (Author), Alaa B Alsaad (Author), Ghadah F Alotaibi (Author), Fahad M Alsaif (Author), Hend M Alotaibi (Author)
• Format: Bog
• Udgivet: Wolters Kluwer Medknow Publications, 2022-01-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

Background: The use of tumor necrosis factor-α inhibitors (TNFi) has been associated with an increased risk latent tuberculosis (TB) reactivation. The role of TB screening assays in monitoring patients during TNFi therapy remains uncertain. Spontaneous conversions and reversions have been described....